| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Peptron Inc (KQ: 087010)
087010 Technical Analysis
5
| As on 11th Jul 2023 087010 STOCK Price closed @ 16470.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 9140.47 & Strong Buy for SHORT-TERM with Stoploss of 9495.82 we also expect STOCK to react on Following IMPORTANT LEVELS. |
087010STOCK Price
| Open | 13320.00 | Change | Price | % |
| High | 16900.00 | 1 Day | 2940.00 | 21.73 |
| Low | 13320.00 | 1 Week | 2790.00 | 20.39 |
| Close | 16470.00 | 1 Month | 8770.00 | 113.90 |
| Volume | 2325808 | 1 Year | 6120.00 | 59.13 |
| 52 Week High 14600.00 | 52 Week Low 7150.00 | ||||
KQ Korea Most Active Stocks
| 001470 | 4730.00 | -4.25% |
| 001470 | 4730.00 | -4.25% |
| 022100 | 20250.00 | 27.36% |
| 032820 | 1581.00 | 11.65% |
| 027580 | 2190.00 | 7.09% |
| 006910 | 4025.00 | 8.93% |
| 000040 | 670.00 | 12.42% |
| 000040 | 670.00 | 12.42% |
| 073640 | 7470.00 | 23.88% |
| 214870 | 1383.00 | -27.44% |
KQ Korea Top Gainers Stocks
KQ Korea Top Losers Stocks
| 087010 Daily Charts |
087010 Intraday Charts |
Whats New @ Bazaartrend |
087010 Free Analysis |
|
|
087010 Important Levels Intraday
| RESISTANCE | 23368.66 |
| RESISTANCE | 21156.22 |
| RESISTANCE | 19788.66 |
| RESISTANCE | 18421.10 |
| SUPPORT | 14518.90 |
| SUPPORT | 13151.34 |
| SUPPORT | 11783.78 |
| SUPPORT | 9571.34 |
087010 Forecast May 2024
| 4th UP Forecast | 18589.7 |
| 3rd UP Forecast | 17909.9 |
| 2nd UP Forecast | 17489.7 |
| 1st UP Forecast | 17069.5 |
| 1st DOWN Forecast | 15870.5 |
| 2nd DOWN Forecast | 15450.3 |
| 3rd DOWN Forecast | 15030.1 |
| 4th DOWN Forecast | 14350.3 |
087010 Weekly Forecast
| 4th UP Forecast | 18589.70 |
| 3rd UP Forecast | 17909.90 |
| 2nd UP Forecast | 17489.70 |
| 1st UP Forecast | 17069.50 |
| 1st DOWN Forecast | 15870.50 |
| 2nd DOWN Forecast | 15450.30 |
| 3rd DOWN Forecast | 15030.10 |
| 4th DOWN Forecast | 14350.30 |
087010 Forecast2024
| 4th UP Forecast | 35450.9 |
| 3rd UP Forecast | 29363.7 |
| 2nd UP Forecast | 25600.9 |
| 1st UP Forecast | 21838.2 |
| 1st DOWN Forecast | 11101.8 |
| 2nd DOWN Forecast | 7339.05 |
| 3rd DOWN Forecast | 3576.35 |
| 4th DOWN Forecast | -2510.95 |
Peptron Inc ( KQ Korea Symbol : 087010 )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
087010 Business Profile
Peptron, Inc. engages in the development of peptide-based medicines to treat chronic diseases. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, and puberty; SR-Octreotide (PT201) for the treatment of acromegaly; SR-Exenatide (PT302) to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea. Address: 37-24, Yuseong-daero 1628 beon-gil, Daejeon, South Korea, 340-54
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service